DocCheck (AJ91.DE) Stock Price
DocCheck Price
Revenue has compounded at 7.7% per year over the past 19 years to 55.32 M EUR. Earnings per share have grown at 10.3% per year over the last 19 years. DocCheck's net margin stands at 9.6%, down from 13.3% several years earlier. DocCheck currently offers a dividend yield of about 6.88%. The payout ratio is around 71% of earnings. The dividend has grown at 8.8% per year over the past 13 years. The stock trades about 2% above its 52-week low.
DocCheck stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of DocCheck over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how DocCheck stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing DocCheck's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | DocCheck Price |
|---|---|
| 9/22/2026 | 10.90 EUR |
| 9/18/2026 | 11.10 EUR |
| 9/17/2026 | 11.20 EUR |
| 9/16/2026 | 11.10 EUR |
| 9/15/2026 | 11.00 EUR |
| 9/14/2026 | 10.90 EUR |
| 9/11/2026 | 11.00 EUR |
| 9/10/2026 | 11.10 EUR |
| 9/9/2026 | 11.20 EUR |
| 9/8/2026 | 11.40 EUR |
| 9/7/2026 | 11.40 EUR |
| 9/4/2026 | 11.00 EUR |
| 9/3/2026 | 11.00 EUR |
| 9/2/2026 | 11.00 EUR |
| 9/1/2026 | 11.40 EUR |
| 8/31/2026 | 11.40 EUR |
| 8/28/2026 | 11.10 EUR |
| 8/27/2026 | 10.90 EUR |
| 8/26/2026 | 10.90 EUR |
| 8/25/2026 | 10.90 EUR |
| 8/21/2026 | 10.90 EUR |
| 8/20/2026 | 10.80 EUR |
| 8/19/2026 | 10.90 EUR |
| 8/18/2026 | 10.70 EUR |
| 8/17/2026 | 10.80 EUR |
| 8/14/2026 | 11.10 EUR |
| 8/13/2026 | 11.10 EUR |
| 8/12/2026 | 11.20 EUR |
| 8/11/2026 | 11.60 EUR |
| 8/10/2026 | 11.40 EUR |
DocCheck Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
DocCheck Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM EUR |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM EUR |
| EBITM EUR |
| EBIT MARGIN% |
| NET INCOMEM EUR |
| NET INCOME GROWTH% |
| DIVIDENDDIV.EUR |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.00 | 17.00 | 18.00 | 17.00 | 2.00 | 26.00 | 25.00 | 28.00 | 28.00 | 32.00 | 63.00 | 85.00 | 60.00 | 53.00 | 53.00 | 55.00 |
| -6.25 | 13.33 | 5.88 | -5.56 | -88.24 | 1,200.00 | -3.85 | 12.00 | – | 14.29 | 96.88 | 34.92 | -29.41 | -11.67 | – | 3.77 |
| 60.00 | 58.82 | 22.22 | 23.53 | 600.00 | 26.92 | 28.00 | 28.57 | 28.57 | 25.00 | 28.57 | 24.71 | 23.33 | 22.64 | 18.87 | 21.82 |
| 9.00 | 10.00 | 4.00 | 4.00 | 12.00 | 7.00 | 7.00 | 8.00 | 8.00 | 8.00 | 18.00 | 21.00 | 14.00 | 12.00 | 10.00 | 12.00 |
| – | 1.00 | 1.00 | 1.00 | – | 3.00 | 4.00 | 3.00 | 3.00 | 4.00 | 13.00 | 16.00 | 10.00 | 3.00 | 6.00 | 7.00 |
| – | 5.88 | 5.56 | 5.88 | – | 11.54 | 16.00 | 10.71 | 10.71 | 12.50 | 20.63 | 18.82 | 16.67 | 5.66 | 11.32 | 12.73 |
| – | 1.00 | 1.00 | 1.00 | – | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 9.00 | 11.00 | 6.00 | 2.00 | 5.00 | 5.00 |
| – | – | – | – | – | – | – | – | – | 50.00 | 200.00 | 22.22 | -45.45 | -66.67 | 150.00 | – |
| – | – | 0.25 | 0.20 | 0.20 | 0.35 | 0.40 | 0.40 | 0.40 | 0.40 | 0.10 | 1.00 | 1.00 | 0.75 | 0.50 | 0.75 |
| – | – | – | -20.00 | – | 75.00 | 14.29 | – | – | – | -75.00 | 900.00 | – | -25.00 | -33.33 | 50.00 |
| 5.28 | 5.28 | 4.99 | 4.99 | 4.99 | 5.00 | 5.01 | 5.03 | 5.02 | 4.99 | 5.05 | 5.07 | 5.06 | 5.07 | 5.07 | 5.07 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales DocCheck generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue DocCheck retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare DocCheck's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares DocCheck has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against DocCheck's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
DocCheck stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
DocCheck Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
DocCheck business model & stock analysis
DocCheck SWOT Analysis
Strengths
- DocCheck AG has a strong brand reputation and recognition in the healthcare industry.
- The company offers a comprehensive range of digital solutions and services tailored for healthcare professionals and organizations.
- DocCheck AG has established a large and loyal customer base, which contributes to stable revenue streams.
Weaknesses
- The company heavily relies on its digital platform, which makes it vulnerable to potential technological disruptions or cybersecurity threats.
- DocCheck AG faces competition from other established players in the healthcare technology sector, which may limit its market share.
- The company's growth is dependent on expanding its customer base and acquiring new markets, which can be challenging in highly regulated healthcare environments.
Opportunities
- The increasing adoption of digital solutions in the healthcare industry presents an opportunity for DocCheck AG to expand its services and reach a broader market.
- The company can leverage data analytics and artificial intelligence to develop innovative solutions that improve patient care and operational efficiency.
- International expansion into new markets with less competition can help DocCheck AG accelerate growth and diversify its revenue streams.
Threats
- Changing regulatory policies and compliance requirements in the healthcare industry can pose challenges for DocCheck AG's operations and product development.
- The emergence of new competitors or disruptive technologies may impact the company's market position and profitability.
- Economic downturns or financial instability could lead to reduced healthcare spending, which could affect the demand for DocCheck AG's services.
DocCheck Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
DocCheck historical P/E ratio, EBIT multiple, and P/S ratio
DocCheck annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down DocCheck's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in DocCheck's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare DocCheck's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
DocCheck shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
DocCheck Dividend History
14 years of dividend payments
DocCheck dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
DocCheck dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
DocCheck shareholder structure
| % | Name |
|---|---|
55.83017% | |
16.09005% | |
7.76002% | |
0.15767% |
DocCheck Beneficial Ownership Filings (SEC 13D/G)
DocCheck Executives and Management Board
7 members · 14 % women
Dr. Frank Antwerpes
Chief Executive Officer · since 2023
249,996.00 EUR
Management
Mr. Thilo Koelzer
Chief Operating Officer, Member of the Management Board
Mr. Philip Stadtmann
Chief Financial Officer, Member of the Management Board
Mr. Jens Knoop
Chief Technology Officer, Member of the Management Board
Board of Directors
Dr. Joachim Pietzko
Chairman of the Supervisory Board
Mr. Winfried Leimeister
Member of the Supervisory Board
Ms. Karin Immenroth
Member of the Supervisory Board
Frequently asked questions about DocCheck
The business model of DocCheck AG revolves around providing an online platform and services for healthcare professionals. DocCheck offers a range of products such as DocCheck Login, which enables secure access to medical content, and the Medicus app that allows doctors to access medical information on their mobile devices. Additionally, the company offers DocCheck Shop, an e-commerce platform for medical supplies and equipment. DocCheck AG aims to connect healthcare professionals, facilitate information exchange, and provide convenient solutions for the medical community. Its platform and services play a crucial role in supporting healthcare professionals in their daily work and improving patient care.
DocCheck AG is primarily active in the healthcare industry.
The main competitors of DocCheck AG in the market include Medscape, Doximity, and Epocrates.
DocCheck AG is a renowned company with a rich history in the medical industry. Founded in Germany, it has become a leading provider of digital solutions for healthcare professionals. DocCheck's journey began in 1996, and since then, it has focused on developing innovative tools and services to support medical practitioners in their daily work. The company's expertise lies in its comprehensive online platform, which facilitates communication, knowledge sharing, and collaboration among healthcare professionals worldwide. With a strong commitment to quality and reliability, DocCheck AG has earned a solid reputation as a trusted partner in the medical community, continuously striving to enhance medical practice through technological advancements.
DocCheck AG has achieved significant milestones in its journey as a leading provider in the healthcare industry. The company has successfully established itself as a trusted platform for the exchange of medical knowledge, connecting healthcare professionals worldwide. With a strong focus on innovation, DocCheck AG has developed and launched various solutions to support healthcare providers, such as DocCheck Flexikon, an extensive medical lexicon, and DocCheck News, a platform for up-to-date medical information. Moreover, the company has forged partnerships with renowned institutions and organizations, enabling it to expand its reach and impact within the healthcare community. DocCheck AG continues to revolutionize the medical sector, enhancing communication, and facilitating collaboration among healthcare professionals.
DocCheck AG is primarily present in Germany and serves as a leading provider of online services for the healthcare industry. With a strong focus on the German market, DocCheck AG offers a wide range of innovative products and solutions to medical professionals, pharmaceutical companies, and healthcare organizations. Their comprehensive platform and services enable seamless collaboration and communication within the healthcare community, making it a trusted and preferred choice in Germany's healthcare sector.
DocCheck AG represents values such as trust, innovation, and collaboration in the healthcare industry. With a corporate philosophy centered around facilitating communication and knowledge sharing among healthcare professionals, DocCheck AG prioritizes the needs of its users and the quality of their services. Through their platform, they provide a secure environment for doctors, pharmacists, and other medical professionals to connect, exchange information, and access reliable medical content. With a strong focus on digitalization and technology-driven solutions, DocCheck AG aims to enhance the efficiency and effectiveness of healthcare professionals, ultimately improving patient care and outcomes.
The DocCheck share (AJ91.DE) is listed on 5 stock exchanges, including: SIX (Zürich) (AJ91.SW), XETRA (AJ91.DE), Frankfurt (AJ91.F), München (AJ91.MU), Düsseldorf (AJ91.DU).
The DocCheck AG is a leading provider of digital services and products in the healthcare industry. The company was founded in 1996 and is headquartered in Cologne. DocCheck's offerings are tailored to doctors, pharmacists, and medical professionals. DocCheck's business model is divided into various segments. One important segment is the digital communication and networking of medical professionals. DocCheck utilizes its own platform, the DocCheck Community, to facilitate exchange between doctors and pharmacists. The platform also offers various features such as news sections, forums, and job opportunities. DocCheck also provides specific apps for certain medical fields, which enable quick and convenient access to important information in the medical field. Another segment of DocCheck is the distribution of medical products needed by doctors and pharmacists. The company offers a wide range of medical products that can be easily ordered online by professionals. DocCheck's product range now also includes medical devices and furnishings for doctor's offices and clinics. A very important service offered by DocCheck is the continued education of medical professionals. For this purpose, the company closely collaborates with the international medical community and offers various e-learning modules and seminars for doctors and pharmacists. The courses are divided into different subjects and ensure that medical professionals stay up to date with the latest advancements in science. Certification for completed courses ensures that the continuing education process is documented and traceable for other industry professionals. DocCheck's business model is based on creating added value for medical professionals. By utilizing the DocCheck platform and the offered services, doctors, pharmacists, and medical professionals can work faster and more effectively and have easier access to important information and products. Through close collaboration with various companies and professionals in the medical industry, DocCheck promotes innovation and development in medical technology. Overall, DocCheck's business model is focused on long-term growth and support for medical professionals. The digital networking and access to important information and products facilitate the work of medical professionals in their everyday lives. With the combination of digital services, distribution, and continued education, DocCheck strengthens the medical industry and the work of medical professionals.
The revenue cannot currently be calculated for DocCheck.
The profit cannot currently be calculated for DocCheck.
The P/E ratio cannot be calculated for DocCheck at the moment.
The P/S cannot be calculated for DocCheck currently.
The Eulerpool Quality Score for DocCheck is 4/10.
The ISIN of DocCheck is DE000A1A6WE6. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of DocCheck is A1A6WE. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of DocCheck is AJ91.DE. The ticker symbol is used to trade DocCheck shares on the stock exchange.
Over the past 12 months, DocCheck paid a dividend of 0.75 EUR . This corresponds to a dividend yield of about 6.88 %. For the coming 12 months, DocCheck is expected to pay a dividend of 0.75 EUR.
The current dividend yield of DocCheck is 6.88 %.
DocCheck pays a dividend, distributed in the months of June, May.
DocCheck paid dividends every year for the past 14 years.
For the upcoming 12 months, dividends amounting to 0.75 EUR are expected. This corresponds to a dividend yield of 6.76 %.
DocCheck is assigned to the 'Health' sector.
To receive the latest dividend of DocCheck from 6/2/2025 amounting to 0.75 EUR, you needed to have the stock in your portfolio before the ex-date on 5/29/2025.
The last dividend was paid out on 6/2/2025.
In the year 2025, DocCheck distributed 0.75 EUR as dividends.
The dividends of DocCheck are distributed in EUR.
DocCheck stock
DocCheck Peer Group
DocCheck Ticker
DocCheck FIGI
All fundamentals and in-depth analysis of DocCheck
Our stock analysis for DocCheck stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DocCheck. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.